Drug survival study looks at what lasts longest in RA, axSpA, PsA, and psoriasisMarch 11, 2022Psoriatic Arthritis
One-third of psoriatic arthritis patients could have metabolic syndrome, data analysis findsMarch 4, 2022Psoriatic Arthritis
PsA: TNF-blockade does not downregulate IL-17 cytokine and receptor protein levelFebruary 23, 2022Psoriatic Arthritis
Sex-specific adjustments in management strategy may be beneficial in early PsAFebruary 23, 2022Psoriatic Arthritis
PsA: Patients have high anxiety levels that decline after initiation of biologicsFebruary 23, 2022Psoriatic Arthritis
MIC of PASDAS could serve as an additional tool to understand patients’ perspectives of PsAFebruary 23, 2022Psoriatic Arthritis
